New biocompatible titanium alloys for next-generation metallic biomaterials

用于下一代金属生物材料的新型生物相容性钛合金

• 批准号: DP210101862
• 负责人: Prof Cuie Wen
• 金额: $ 33.8万
• 依托单位: RMIT University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2024-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP210101862
• 关键词: New; biocompatible; titanium; alloys; next

This project aims to develop a new class of titanium alloy biomaterials with enhanced mechanical compatibility, biocompatibility, and bio-functionality. The project expects to generate new knowledge in phase transformation mechanisms and advanced surface modification techniques for these alloys. Expected outcomes also include developments in phase transformation theories that enable high yield strength and low Young's modulus, and innovations in manufacturing techniques for new titanium alloys. This project will provide significant benefits to both Australian healthcare providers and bone-implant recipients through greater implant lifespans, improved patient outcomes and valuable savings to the healthcare system.

该项目旨在开发一类具有增强机械相容性、生物相容性和生物功能的新型钛合金生物材料。该项目期望产生有关这些合金的相变机制和先进表面改性技术的新知识。预期成果还包括实现高屈服强度和低杨氏模量的相变理论的发展，以及新型钛合金制造技术的创新。该项目将通过延长植入物的使用寿命、改善患者的治疗效果并为医疗保健系统节省宝贵的费用，为澳大利亚医疗保健提供者和骨植入接受者带来显着的好处。